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The cell biological hypothesis ofDuchennemuscular dystrophy
assumes that deficiency in the membrane cytoskeletal element
dystrophin triggers a loss in surface glycoproteins, such as -
dystroglycan, thereby rendering the sarcolemmal membrane
more susceptible to micro-rupturing. Secondary changes in ion
homeostasis, such as increased cytosolic Ca2 levels and
impaired luminal Ca2 buffering, eventually lead to Ca2-
induced myonecrosis. However, individual muscle groups
exhibit a graded pathological response during the natural
time course of x-linkedmuscular dystrophy. The absence of the
dystrophin isofomDp427 does not necessarily result in a severe
dystrophic phenotype in all muscle groups. In the dystrophic
mdx animal model, extraocular and toe muscles are not as
severely affected as limb muscles. Here, we show that the
relative expression and sarcolemmal localization of the central
trans-sarcolemmal linker of the dystrophin-glycoprotein com-
plex, -dystroglycan, is preserved in mdx extraocular and toe
fibres by means of two-dimensional immunoblotting and
immunofluorescence microscopy. Thus, with respect to im-
provingmyology diagnostics, the relative expression levels of-
dystroglycan appear to represent reliable markers for the
severity of secondary changes in dystrophin-deficient fibres.
Immunoblotting and enzyme assays revealed that mdx toe
muscle fibres exhibit an increased expression and activity of the
sarcoplasmic reticulum Ca2-ATPase. Chemical crosslinking
studies demonstrated impaired calsequestrin oligomerization
in mdx gastrocnemius muscle indicating that abnormal calse-
questrin clustering is involved in reduced Ca2 buffering of the
dystrophic sarcoplasmic reticulum. Previous studies have
mostly attributed the sparing of certain mdx fibres to the
special protective properties of small-diameter fibres. Our
study suggests that the rescue of dystrophin-associated glyco-
proteins, and possibly the increased removal of cytosolic Ca2
ions, might also play an important role in protecting muscle
cells from necrotic changes.
Introduction
Duchenne muscular dystrophy represents the most common
inherited neuromuscular disorder and the most prevalent and
lethal gender-specific genetic disease of childhood (Emery,
2002). An established animal model of x-linked muscular
dystrophy is the mdx mouse (Bulfield et al., 1984), which is
missing the dystrophin isoform Dp427 due to a point mutation
(Sicinski et al., 1989). Although not a perfect replica of the
human pathology, this dystrophic animal model exhibits many
cellular and molecular abnormalities seen in x-linked human
muscular dystrophy. Skeletal muscle fibres from mdx mice
exhibit elevated levels of serum creatine kinase (Bulfield et al.,
1984), are more susceptible to osmotic shock (Menke and
Jockusch, 1991), exhibit segmental necrosis (Torres and Du-
chen, 1987), show stretch-induced injury (Lynch et al., 2000), as
well as abnormal excitation-contraction coupling (DeLuca
et al., 2001) and a drastic reduction in dystrophin-associated
glycoproteins (Culligan et al., 2001). This makes it a suitable
disease model (Allamand and Campbell, 2000), widely em-
ployed for testing novel therapeutic strategies such asmyoblast
transfer therapy (Partridge and Davies, 1995), gene therapy
(Ahmad et al., 2000; Hartigan-O×Connor and Chamberlain,
2000; Wang et al., 2000) and pharmacological intervention
(Badalamente and Stracher, 2000; Tidball and Spencer, 2000;
Bogdanovich et al., 2002). In addition, mdx muscle is used to
evaluate pathophysiological hypotheses by studying the cell
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biological effects following genetic modifications (Wehling
et al., 2001).
With a view to developing new treatment strategies for
muscular dystrophies, medical problems commonly associated
with myoblast and gene transfer therapy are an insufficient
therapeutic effect, immune rejection and cytotoxic side effects.
To overcome these biomedical obstacles, an alternative ap-
proach to establish novel therapeutic targets is the examination
of naturally protected skeletal muscle fibres (Porter, 1998;
Andrade et al., 2000). This might help to better understand
compensatory mechanisms counteracting the pathophysiology
of Duchenne muscular dystrophy and could thus lead to the
discovery of novel pathways or receptor classes involved in the
endogenous elimination of myonecrosis. Two muscle groups
which are deficient in the dystrophin isoform Dp427, but only
show a mild dystrophic phenotype, are extraocular and toe
muscles from the mdx animal model (Matsumura et al., 1992).
While the sparing of muscle fibres is at least partially due to the
special protective properties of fast-twitching small-diameter
fibres (Karpati et al., 1988; Andrade et al., 2000), the up-
regulation of utrophin is also implicated as a compensatory
mechanism which rescues the sarcolemmal integrity in these
unique cells (Porter et al., 1998). The absence of the membrane
cytoskeletal component dystrophin triggers a drastic reduction
in several crucial sarcolemmal glycoproteins (Ohlendieck and
Campbell, 1991) named dystroglycan, sarcoglycans, dystrobre-
vin, syntrophin and sarcospan (Culligan et al., 1998). Inmdx toe
muscles these dystrophin-associated proteins are not as se-
verely affected as in dystrophic mdx leg muscles (Dowling
et al., 2002). Since the disintegration of the dystrophin-glyco-
protein complex is postulated to interrupt the trans-sarcolem-
mal linkage between the actin membrane cytoskeleton and the
extracellularmatrix element laminin, thereby renderingmuscle
fibres more susceptible to necrosis (Ohlendieck, 1996; Cohn
and Campbell, 2000), the rescue of dystrophin-associated
glycoproteins may play a key role in preventing the dystrophic
phenotype.
Ion flux through Ca2-leak channels appears to be respon-
sible for an elevatedCa2-dependent net degradation ofmuscle
proteins in dystrophic muscle cells (Alderton and Steinhardt,
2000). Although conflicting reports have been published on the
extent of perturbation of Ca2 homeostasis in dystrophic fibres
(Gillis, 1996; Culligan and Ohlendieck, 2002), recent studies
have established that the cytosolic Ca2 overload in dystrophin-
deficient muscle cells is not global but restricted to the
subsarcolemmal domain (Mallouk et al., 2000). In addition,
abnormal Ca2 cycling through the lumen of the sarcoplasmic
reticulum (Culligan et al., 2002) and mitochondria (Robert
et al., 2001) is also involved in the muscular degeneration
process. In dystrophic mdx leg skeletal muscle, the expression
of the four main Ca2-regulatory elements of the excitation-
contraction-relaxation cycle, i.e. the voltage-sensing dihydro-
pyridine receptor, the ryanodine receptor Ca2-release chan-
nel, the Ca2-binding protein calsequestrin and the sarcoplas-
mic reticulum Ca2-ATPase, is not modified (Culligan et al.,
2002). It was therefore of interest to study whether a
compensatory change in the relative abundance of these key
ion-regulatory muscle proteins exists in naturally protected
mdx toe and extraocular fibres, as compared to more severely
affected dystrophicmdx legmuscles.Our analysis indicates that
a selective up-regulation of the sarcoplasmic reticulum Ca2
pump might be involved in the fast removal of excess cytosolic
Ca2 ions thereby reducing the detrimental effects of myo-
necrosis inmdx toe fibres. These findingsmight have important
implications for the future design of therapeutic approaches to
treat x-linked muscular dystrophy, since the elimination of
Ca2-dependent proteolysis appears to be a promising newway
to counteract dystrophic changes in muscle cells (Badalamente
and Stracher, 2000).
Materials and methods
Materials
Protease inhibitors and acrylamide stock solutions were obtained from
Boehringer Mannheim (Lewis, East Sussex, UK). Immobilon-P nitro-
cellulosemembranes were fromMillipore Corporation (Bedford,MA).
Chemiluminescence substrates were purchased from Perbio Science
UK Ltd. (Tattenhall, Cheshire, UK). Superfrost Plus positively charged
microscope slideswere fromMenzel-Gl‰ser (Braunschweig,Germany).
All other chemicals used were of analytical grade and purchased from
Sigma Chemical Company (Poole, Dorset, UK).
Antibodies
Primary antibodies were purchased fromNovocastra Laboratories Ltd.,
Newcastle upon Tyne, UK (mAb NCL-43 against -dystroglycan and
mAbDYS-2 to the carboxy-terminus of the dystrophin isoformDp427),
Affinity Bioreagents, Golden, CO, USA (mAb VIIID12 to fast
calsequestrin;mAb IIH11 to the fast SERCA1 isoformof Ca2-ATPase;
and mAb 20A to the 2-subunit of the dihydropyridine receptor), and
Upstate Biotechnology, Lake Placid, NY, USA (mAb VIA41 to -
dystroglycan) and Sigma Chemical Company (pAb to laminin).
Fluorescein-, rhodamine- and peroxidase-conjugated secondary anti-
bodies were obtained from Boehringer Mannheim.
Animals
Dystrophin-deficient male mdx/y mice, which are missing the Dp427
dystrophin isoform due to a point mutation in exon 23 (Sicinski et al.,
1989), were obtained from Jackson Laboratory (Bar Harbor, Maine,
USA) through the Biomedical Facility of the National University of
Ireland, Dublin. In order to compare the relative expression levels of -
dystroglycan in normal and mdx gastrocnemius, extraocular fibres and
toe muscles, tissue specimens were prepared for both cell biological and
biochemical analyses. For immunofluorescence microscopy, muscle
specimens were carefully dissected and immediately quick-frozen in
liquid nitrogen-cooled isopentane, transported on dry ice and stored at
70 C prior to cryosectioning. For immunoblot analysis, skeletal
muscle samples were quick-frozen in liquid nitrogen, transported in a
container with dry ice and then stored at 70 C prior to homogeniza-
tion.
Immunofluorescence microscopy
For the comparative immuno-decoration of normal and mdx muscle
tissue sections, 12-m cryosections were prepared using a standard
cryostat (Microm, Heidelberg, Germany) and mounted on Superfrost
Plus positively chargedmicroscope slides. Fixation, blocking, incubation
with primary antibodies, washing steps, incubation with secondary
antibodies, as well as image acquisition were performed by established
methodology (Culligan et al., 2001). For double-immunostaining pro-
cedures, a mixture of the appropriate primary antibodies was applied to
tissue sections for 1 h at 37 C, cryosections were washed, and then
separately incubated for 30 min each with the appropriate secondary
antibodies, i.e. a fluorescein- or rhodamine-conjugated probe. Incuba-
tion with the DNA-binding dye diamidino-phenyindole (DAPI) was
used to label nuclei.
Membrane preparation
In order to compare the relative expression levels of -dystroglycan in
normal and mdx leg muscle, extraocular muscle and toe muscle by
immunoblotting, crude microsomal membrane vesicles were isolated
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from tissue homogenates by an established protocol at 0 ± 4 C (Glover
et al., 2002) in the presence of a protease inhibitor cocktail (0.2 mM
Pefabloc, 1.4 M pepstatin A, 0.3 M E-64, 1 M leupeptin, 1 mM
EDTA, and 0.5 Msoybean trypsin inhibitor) (Murray andOhlendieck,
1997). Microsomal pellets were resuspended at a protein concentration
of 10 mg/ml and used immediately for gel electrophoretic separation
and immunoblot analysis. The protein concentration of isolated
membrane vesicles was determined by the method of Bradford (1976),
using bovine serum albumin as a standard. Comparative enzyme assays
to determine Ca2-ATPase activity were performed by standard
methods, recently optimized in our laboratory for the analysis of muscle
membrane samples (Culligan et al., 2002). A direct colorimetric assay
procedure using a malachite green-molybdate-polyvinyl alcohol mixed
reagent was employed. Ca2-ATPase activity was calculated by compar-
ison of measurements with a potassium dihydrogen phosphate standard
graph.
Gel electrophoresis and immunoblot analysis
Because only restricted amounts of microsomal membranes could be
obtained from extraocular and toe muscle fibres, a one- and two-
dimensional Mini-MP3 electrophoresis system and mini blotting cell
fromBio-RadLaboratories (HempelHempstead,Herts.,UK)wasused.
For the one-dimensional gel electrophoretic separation of microsomal
muscle proteins, sodium dodecyl sulfate polyacrylamide gel electro-
phoresis under reducing conditions was carried out by standard
methodology (Laemmli, 1970) using 5% or 7% resolving gels and
20 g protein per lane (Dowling et al., 2002). Two-dimensional electro-
phoresis was carried out by a technique recently optimized for the
analysis of muscle membrane proteins (Froemming and Ohlendieck,
2001). For blotting experiments, separated microsomal muscle proteins
were electrophoretically transferred for 1 h at 100 Vonto nitrocellulose
membranes by themethod of Towbin et al. (1979).Membrane blocking,
incubation with primary antibodies, washing steps, incubation with
peroxidase-conjugated secondary antibodies, visualization of immuno-
decorated protein bands and densitometric scanning of developed
immunoblots were carried out as previously described in detail
(Harmon et al., 2001). Densitometric scanning of enhanced chemilu-
minescence blots was performed on a Molecular Dynamics 300S
computing densitometer (Sunnyvale, CA, USA) with ImageQuant
V3.0 software.
Results
An established feature of dystrophin-deficient skeletal muscle
fibres is a drastic reduction in various surface glycoproteins
(Ohlendieck and Campbell, 1991). Necrotic changes, however,
do not appear to occur in all mutant muscle fibre species to the
same extent. It was therefore of interest to study the fate of a
key dystrophin-associated glycoprotein, -dystroglycan, in
muscle tissues that are relatively unaffected, such as mdx
extraocular fibres (Porter, 1998) and mdx toe fibres (Dowling
et al., 2002). The relative expression level of-dystroglycanwas
studied in normal and mdx gastrocnemius, extraocular and toe
membranes using two-dimensional immunoblotting (Fig. 1)
and immunofluorescence microscopy (Fig. 2). Since abnormal
Ca2 homeostasis might be involved in rendering dystrophin-
deficient muscle fibres more susceptible to necrosis (Culligan
and Ohlendieck, 2002), the biochemical and cell biological
status of important Ca2-handling proteins was determined
(Figs. 3 ± 5).
Preserved -dystroglycan expression in mdx
extraocular and toe muscle fibres
Prior to our comparative immunoblot analysis of -dystrogly-
can expression in gastrocnemius, extraocular and toe fibres, the
mutant status of the mdx animals had to be established. All
three mdx tissues clearly exhibited a lack in the dystrophin
protein band of apparent 427 kDa (not shown). Standard one-
dimensional immunoblotting confirmed the previously shown
dramatic reduction in -dystroglycan in dystrophin-deficient
mdx gastrocnemius membrane preparations (not shown). To
complement these findings by the more discriminatory tech-
nique of two-dimensional gel electrophoresis, muscle mem-
branes were separated in the first dimension by isolectric
focusing and in the second dimension by SDS polyacrylamide
gel electrophoresis. The four two-dimensional immunoblots
shown in Figure 1C±F revealed that both the relative expres-
sion and isoelectric point of -dystroglycan is not affected in
dystrophin-deficient extraocular and toe fibres. In contrast, the
expression of -dystroglycan was drastically reduced in mdx
gastrocnemius membranes (Fig. 1A, B).
Preserved sarcolemma localization of -
dystroglycan in mdx extraocular muscle fibres
Comparative immunofluorescence microscopy confirmed the
sarcolemmal localization of -dystroglycan in normal gastro-
cnemius muscle and its drastically reduced expression in the
dystrophin-deficient mdx gastrocnemiusmuscle periphery (not
shown). In analogy to the results of the comparative immuno-
blot analysis presented in Figure 1, immunofluorescence mi-
croscopy of transversely cut extraocular fibres demonstrated a
preserved sarcolemmal localization of -dystroglycan in mdx
extraocular muscles (Fig. 2). Although fluorescein labeling is
only a semi-quantitative tool, direct comparison of relative
intensity levels indicate similar expression levels of -dystro-
Fig. 1. Comparative two-dimensional immunoblot analysis of -
dystroglycan expression. Crude microsomal membranes from normal
gastrocnemius (A), mdx gastrocnemius (B), normal extraocular (C),
mdx extraocular (D), normal toe (E) and mdx toe (F) muscle
homogenates were separated in the first dimension by isolelectric
focusing and in the second dimension by SDS polyacrylamide gel
electrophoresis. Identical two-dimensional blots were labeled with an
antibody against 43-kDa -dystroglycan. The pH values of the first
dimension gel system and molecular mass standards (in kDa) of the
second dimension are indicated on the top and on the left of the panels,
respectively.
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glycan in both normal and mdx fibres (not shown). In contrast
to dystrophic gastrocnemius, the degree of central nucleation is
less in extraocular mdx fibres (Fig. 2C). To illustrate this
differing DAPI staining pattern and to show the higher
expression levels of -dystroglycan, representative gastrocne-
mius and extraocular fibres are shown in Figure 2A, B. This
immunofluorescence micrograph clearly demonstrates the less
intense green fluorescein labeling of the cell periphery and the
higher degree of centrally located DAPI-stained nuclei in mdx
gastrocnemius sections. Immunofluorescence labeling of toe
fibres did not result in strong enough fluorescein staining
patterns above background (not shown), so the cell biological
analysis of mdx toe fibres could not be performed.
Status of Ca2-handling proteins in mdx tissues
AbnormalCa2homeostasis is implicated in secondary changes
leading to muscle cell degeneration. The main ion-regulatory
elements involved in the regulation of the excitation-contrac-
tion-relaxation cycle in skeletal muscle fibres are the voltage-
sensing dihydropyridine receptor of the transverse tubules, the
ryanodine receptor Ca2-release channel of the junctional
sarcoplasmic reticulum, the main luminal Ca2-buffering pro-
tein calsequestrin of the terminal cisternae region and the
SERCA isoforms of the sarcoplasmic reticulumCa2-ATPases.
As illustrated in the immunoblot analyses shown in Figure 3A,
the relative expression level of the 63-kDa fast calsequestrin
isoform is relatively comparable between normal and mdx
membranes isolated from gastrocnemius, extraocular and toe
muscles. The same result was found for the 2-subunit of the
transverse-tubular dihydropyridine receptor complex (not
shown). Immunoblotting of extraocular and toe membranes
with antibodies to the RyR1 isoform of the sarcoplasmic
reticulum Ca2-release channel did not result in good enough
labeling above background for a proper comparative study (not
shown). The drastic reduction in calsequestrin-like proteins of
approximately 150 to 220 kDa inmdx legmuscle has previously
been documented (Culligan et al., 2002). Both, extraocular and
toe muscles do not appear to express the same complement of
the high-molecular-mass isoforms of the main Ca2-reservoir
element to the same degree as gastrocnemius fibres (Fig. 3A).
However, extraocular preparations clearly contain the CLP-
220 isoform and this protein is drastically reduced in dystro-
phin-deficient membranes (Fig. 3A). It is not clear whether the
CLP isoforms of calsequestrin represent a separate class of
luminal Ca2-binding proteins or whether these peripheral
proteins of the sarcoplamic reticulum are aggregates of the 63-
kDa calsequestrin monomer (Cala et al., 1990).
 Fig. 2. Peripheral nucleation and preserved -dystroglycan expres-
sion in extraocular mdx fibres. Skeletal muscle specimens were taken
from mdx gastrocnemius (A) and mdx extraocular (B) muscle fibres.
Cryosections were labeled with an antibody to -dystroglycan (-DG)
and the DNA-binding dye diamidino-phenyindole (DAPI). The direct
comparison of the fluorescein labeling intensity of -dystroglycan
demonstrates the higher expression level of this dystrophin-associated
glycoprotein in extraocular fibres, as compared to dystrophic leg
muscle. DAPI staining revealed a high degree of central nucleation in
mdx gastrocnemius sections and more peripheral nucleation in mdx
extraocular fibres. Bar 20 m. (C) Graphical presentation of DAPI
labelling patterns (n 5; ***P 0.001; unpaired t-test). In transverse
cryosections from individual mdx mice, approximately 60 cells were
evaluated for their DAPI staining pattern.
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To address this question and in order to determine whether
the reduction in high-molecular-mass calsequestrin isoforms is
due to decreased expression or impaired oligomerization, we
have performed a chemical crosslinking analysis of microsomal
membranes. Figure 3B shows that in the absence of the
crosslinker probe, normal microsomes exhibit 3 CLP bands,
whilemdxmembranes exhibit a greatly reduced signal for these
proteins. Incubation with increasing concentrations of the
homo-bifunctional hydrophobic 1.2 nm probe dithio-bis-suc-
cinimydyl-propionate (DSP) causes the appearance of an
immuno-decorated band with a very low electrophoretic
mobility in normal membranes. Interestingly, in mdx prepara-
tions, the same crosslinker-induced effect is seen at slightly
higher DSP concentrations. This suggests that the three CLP
bands of approximately 150 kDa, 170 kDa and 220 kDa
represent aggregates of the smaller calsequestrin monomer,
rather than distinct isoforms. The DSP-inducible restoration of
their appearance inmdxmembranes indicates that the reduced
expression of the high-molecular-mass species in dystrophic
microsomes is most likely not due to a loss in individual
isoforms, but because of impaired oligomerization of 63-kDa
calsequestrin units. Since chemical crosslinking experiments
require relatively large amounts of membrane vesicles for the
optmization of the incubation conditions, this analysis could
only be performed with the more abundant material from
normal and mdx gastrocnemius muscle, and not with extraoc-
ular and toe preparations.
Ca2 reuptake is a critical step in muscle relaxation and
changes in the relative expression of the sarcoplasmic reticulum
Ca2-ATPases play a role in certain muscle pathologies such as
Brody×s disease and alcoholic myopathy. We therefore deter-
mined potential changes in the expression levels of the
predominant Ca2 pump isoform, the fast SERCA1 species, in
normal and mdx gastrocnemius, extraocular and toe fibres. As
shown in immunoblot analysis (Fig. 4A), the abundance of
SERCA1 is relatively comparable in control and dystrophic
gastrocnemius and extraocular muscle preparations, but in-
creased inmdx toemicrosomes. In contrast, laminin expression
Fig. 3. Impaired oligomerization of calsequestrin in mdx muscle
fibres. Blots were labeled with monoclonal antibody VIIID12 to
calsequestrin. This antibody recognizes, in addition to the 63-kDa
monomeric CSQ band, also three high-molecular-mass bands of
approximately 150 kDa, 170 kDa and 220 kDa, termed calsequestrin-
like proteins (CLPs). In panel (A), lanes 1 to 6 represent membrane
vesicles derived from normal gastrocnemius, mdx gastrocnemius,
normal extraocular, mdx extraocular, normal toe and mdx toe muscle
homogenates, respectively. Panel (B) shows the immunoblot analysis of
chemically crosslinked gastrocnemius membranes. Lanes 1 to 5
(normal) and lanes 6 to 10 (mdx) represent 0, 12.5, 50, 100, and
200 g dithio-bis-succinimidyl propionate (DSP) crosslinker (XL) per
mg membrane protein, respectively. The positions of immuno-deco-
rated proteins are marked by arrows. Molecular mass standards (in
kDa) are indicated on the left.
Fig. 4. Increased expression of the SERCA1 Ca2-ATPase and up-
regulation of Ca2-ATPase enzyme activity in mdx toe muscle fibres. A
blot was labeled with monoclonal antibody IIH11 against the fast-
twitch SERCA1 isoform of the sarcoplasmic reticulum Ca2-ATPase
(A). Lanes 1 to 6 represent membrane vesicles derived from normal
gastrocnemius, mdx gastrocnemius, normal extraocular, mdx extra-
ocular, normal toe and mdx toe muscle homogenates, respectively. (B)
Graphical representation of the Ca2-ATPase enzyme activity of
normal and mdx membrane preparations (n 5; **P 0.01; unpaired
t-test). Bars 1 to 6 represent membrane vesicles derived from normal
gastrocnemius, mdx gastrocnemius, normal extraocular, mdx extra-
ocular, normal toe and mdx toe muscle homogenates, respectively.
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is unaffected in all three mdx tissues as compared to normal
muscles (not shown). To evaluate whether the increased
SERCA1 abundance in mdx toe has a functional consequence,
we determined the Ca2-ATPase enzyme activity in the six
different muscle preparations. Membranes derived from
homogenized mdx toe fibres exhibited a significant increase
in Ca2-ATPase activity (Fig. 4B) indicating a potential adap-
tive response in these dystrophin-deficient fibres. Comparative
immunofluorescence microscopy revealed that laminin and
Ca2-ATPase localization is unaffected in mdx toe and extra-
ocular fibres (Fig. 5). In contrast to the slightly increased
labeling of the mdx fibre periphery for laminin, no drastic
SERCA up-regulation in mdx fibres was observed (Fig. 5).
Probably the differences in relative density of SERCAunits are
too small to be detected by immunofluorescence labeling.
Discussion
To address the issue of why the absence of the dystrophin
Dp427 isoformdoesnot necessarily result in a severe dystrophic
phenotype, we have analysed two naturally protected muscle
groups, the mdx extraocular fibres and mdx toe muscles
(Matsumura et al., 1992), and have compared them to more
severely affected cells from mdx leg muscles. The challenge
with both extraocular and toe fibres is the restricted amount of
tissue available for immunoblotting procedures. However,
using miniature gel and transfer equipment, highly specific
monoclonal antibodies and the enhanced chemiluminescence
detection technique, it was possible to study the fate of -
dystroglycan in low-abundancemdxmuscle tissues. The sparing
of certain mdx fibres has previously been attributed to the
special protective properties of small-diameter fibres (Karpati
et al., 1988). Here we can show that both extraocular and toe
mdxmuscles exhibit a preserved expression of the critical trans-
sarcolemmal linker element of the dystrophin-glycoprotein
complex, -dystroglycan of apparent 43 kDa. Since the disin-
tegration of the dystrophin-associated glycoprotein complex is
believed to play a central role in the secondary pathophysiology
of several inherited muscular dystrophies (Campbell, 1995;
Ohlendieck, 1996), the rescue of -dystroglycan could be a
relevant factor in the protective phenotype of mdx toe and
Fig. 5. Immunofluorescence localization of Ca2-ATPase in mdx
muscle. Cryosections were labeled with antibodies to the fast-twitch
SERCA1 isoform of the sarcoplasmic reticulum Ca2-ATPase (green)
and laminin (red). Nuclei were stained with the DNA-binding dye
diamidino-phenyindole DAPI (blue). Skeletal muscle specimens were
taken from normal (A, C) and mdx (B, D) extraocular (A, B) and toe
(C, D) muscle fibres. Laminin staining is almost exclusively found in the
cellular periphery and labeling of the Ca2-ATPase occurred mostly in
the internal structures of the fibres. Bar 20 m.
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extraocular fibres. In addition, the increased removal of
cytosolic Ca2 ions from mdx toe fibres, via up-regulation of
the SERCA1 Ca2-ATPase units, might also protect dystro-
phin-deficient muscle cells from Ca2-induced myonecrosis.
The rapid advances in routine molecular analyses of patient
samples has greatly improved the diagnosis of muscle diseases
(Miller and Hoffman, 1994; Hoffman, 1999). However, since
many abnormal proteins are muscle-specific isoforms, current
protein tests still depend on relatively large amounts of muscle
tissue taken by biopsy and can often not properly differentiate
between the various forms of muscular dystrophy affecting
similar proteins (Prior, 1995). With respect to improving the
diagnostics of neuromuscular diseases, this study indicates that
the relative expression levels of -dystroglycan represent a
reliable marker of the severity of secondary changes in
dystrophin-deficient fibres. To avoid the potential misdiagnosis
of muscular dystrophies with overlapping symptoms and to
differentiate between differently affectedmuscle groups within
one individual, the standardized two-dimensional mini blot
screeningwith antibodies to -dystroglycan could be helpful. In
combination with molecular biological assays such as Southern
blotting and the polymerase chain reaction, immunocytochem-
ical evaluations of tissue cryosections and protein gel analysis,
two-dimensional immunoblot analysis could be an extremely
helpful tool in the development of a comprehensive biomedical
algorithm for the rapid differential diagnosis of inherited
muscular dystrophies that directly or indirectly affect the
dystrophin-glycoprotein complex.
The mdx mouse does not exhibit all pathological features of
severe Duchenne muscular dystrophy. Nevertheless, this nat-
ural mutant strain represents the most widely used animal
model of x-linked muscular dystrophy (Watchko et al., 2002).
Deficiency in the Dp427 isoform in mdx skeletal muscle is due
to a stop codon mutation in exon 23 of the dystrophin gene
(Sicinski et al., 1989) and the occurring of a dystrophic process
in mdx muscle is evident by elevated creatine kinase levels
(Bulfield et al., 1984). Although not a perfect replica of human
x-linked muscular dystrophy, the mdx model can certainly be
employed for detailed biochemical and cell biological studies
on the molecular pathogenesis of dystrophin deficiency and to
evaluate novel therapeutic strategies such as gene therapy. The
reduction in dystrophin-associated glycoproteins is clearly the
primary pathophysiological consequence of the deficiency in
the Dp427 isoform (Campbell, 1995; Ohlendieck, 1996). How-
ever, it is not well understood what cascade of secondary
abnormalities leads to muscle weakness. One potential patho-
biochemical pathway involves abnormal Ca2 handling (Alder-
ton and Steinhardt, 2000; Culligan and Ohlendieck, 2002). A
recent survey of the expression patterns of key Ca2-regulatory
membrane proteins in dystrophic mdx leg muscle membranes
revealed that the expression of the ryanodine receptor Ca2-
release channel complex, the dihydropyridine receptor, the
Ca2-ATPase and calsequestrin are not affected in muscular
dystrophy. The only major difference between normal andmdx
microsomes from legmuscle homogenates was a drastic decline
in calsequestrin-like proteins (CLPs) of 150 to 220 kDa
(Culligan et al., 2002). In analogy, the Ca2-binding capacity
of the mdx sarcoplasmic reticulum was shown to be reduced by
approximately 20%. Hence, the reduction in Ca2-binding
proteins might be directly involved in triggering impaired Ca2
sequestration within the lumen of the sarcoplasmic reticulum.
Based on the findings in this report, the hypothesis of
impaired Ca2 buffering being involved in muscular dystrophy
should be revised slightly. Here we could show by chemical
crosslinking analysis that the CLP elements of the terminal
cisternae region appear to be aggregates of calsequestrin and
not distinct high-molecular-mass isoforms. Native membrane-
associated calsequestrin complexes were first stabilized by the
introduction of small covalent linker molecules, followed then
by the solubilization of the membrane structures and subse-
quent electrophoretic separation of crosslinker-stabilized com-
plexes. Thus, the results of this analytical approach are of
physiological significance and represent a well-established
method of determining quaternary structures under native
conditions (Wong, 1991). This indicates that impaired oligo-
merization of calsequestrin units might be a central factor of
reduced Ca2 binding in the dystrophic sarcoplasmic reticulum.
The data agree with the previous finding that calsequestrin
clusters exhibit positive co-operativity with respect to high-
capacity Ca2 binding (Tanaka et al., 1986). Direct protein-
protein interactions play an integral part in regulating luminal
Ca2 concentrations. Upon ion binding to the carboxy-terminal
region, Ca2-induced conformational changes trigger calse-
questrin to fold into amore compact structure (MacLennan and
Reithmeier, 1998;Wang et al., 1998). In addition, calsequestrin
is proposed to act directly as an endogenous regulator of the
junctional ryanodine receptor Ca2-release channel complex
(Ohkura et al., 1998). The luminal Ca2 concentration appears
to influence the probability of Ca2-release channel opening
and thereby modulates Ca2-flux rates from the luminal
sarcoplasmic reticulum (Donoso et al., 1996). Since calseques-
trin appears to be the central regulator of Ca2 cycling through
the sarcoplasmic reticulum and represents an essential me-
diator between excitation-contraction coupling and muscle
relaxation, it is not surprising that impaired physiological
functioning of this terminal cisternae element results in major
tissue damage.
The calcium hypothesis of muscular dystrophy assumes a
complex pathophysiological mechanism of abnormal Ca2
handling by the surface membrane, the transverse tubules, the
sarcoplasmic reticulum and mitochondria (Culligan and Oh-
lendieck, 2002). It is not clear to what extent individual
subcellular domains contribute to overall muscle fibre destruc-
tion. It is, however, well established that dystrophin-deficient
skeletal muscle membranes succumb to exercise-induced
membrane ruptures more frequently than those of normal
fibres (Clarke et al., 1993). Transient micro-ruptures allow for
the insertion of Ca2-leak channels into the skeletal muscle
periphery during the natural processes of cell membrane
resealing. This in turn is believed to result in localized Ca2
elevations, contributing to a cycle of enhanced protease activity
and leak channel activation (Alderton and Steinhardt, 2000).
However, the recent analysis of transgenic mdx muscles, that
exhibit an over-expression of utrophin, questions the role of
mechano-sensitive Ca2-channels in initiating the dystrophic
process (Squire et al., 2002). Possibly, the pathophysiological
modification of other ion-regulatory surface elements precedes
the increased Ca2-leak channel activation, followed by down-
stream alterations of intracellular Ca2 handling. The impaired
clustering of calsequestrin units, as described in this report,may
contribute to decreased luminal Ca2 buffering. This might
indirectly amplify the elevated free cytosolic Ca2 concentra-
tions, which is possibly limited to micro-domains near the
sarcolemma (Mallouk et al., 2000). Hence, disturbed sarcolem-
mal Ca2 fluxes appear to influence overall Ca2 handling
resulting in changes in the oligomerization of a subset of Ca2-
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handling proteins which might be an important factor in the
progressive functional decline of dystrophic muscle fibres. In
this respect, the up-regulation of the sarcoplasmic reticulum
Ca2-ATPase in mdx toe fibres could be a compensatory
mechanism. Possibly the increased removal of cytosolic Ca2
ions plays a role in the rescue of these dystrophin-deficient
fibres, as diagrammatically summarized in Figure 6. Both, the
up-regulation and extra-junctional expression of the autosomal
dystrophin homologue utrophin (Tinsley and Davis, 1993;
Tinsley et al., 1996;Rafael, 1998) and concomitant rescue of the
dystrophin-associated glycoprotein complex, and the removal
of pathophysiological Ca2 levels in the cystosol might be
factors involved in the protected phenotype ofmdx extraocular
and toe fibres.
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